During the last session, Traws Pharma Inc (NASDAQ:TRAW)’s traded shares were 61822.0, with the beta value of the company hitting 1.19. At the end of the trading day, the stock’s price was $1.65, reflecting an intraday loss of -0.60% or -$0.01. The 52-week high for the TRAW share is $19.44, that puts it down -1078.18 from that peak though still a striking 41.21% gain since the share price plummeted to a 52-week low of $0.97. The company’s market capitalization is $9.18M, and the average intraday trading volume over the past 10 days was 0.27 million shares, and the average trade volume was 1.14 million shares over the past three months.

Traws Pharma Inc (NASDAQ:TRAW) trade information

Traws Pharma Inc (TRAW) registered a -0.60% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -0.60% in intraday trading to $1.65, hitting a weekly high. The stock’s 5-day price performance is -10.33%, and it has moved by 23.13% in 30 days. Based on these gigs, the overall price performance for the year is -89.01%. The short interest in Traws Pharma Inc (NASDAQ:TRAW) is 95720.0 shares and it means that shorts have 0.55 day(s) to cover.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 42.51%.

TRAW Dividends

Traws Pharma Inc is due to release its next quarterly earnings on 2025-Mar-31. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Traws Pharma Inc (NASDAQ:TRAW)’s Major holders

Traws Pharma Inc insiders own 18.86% of total outstanding shares while institutional holders control 31.23%, with the float percentage being 38.48%.